UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany

The Lancet regional health. Europe, 2022-01, Vol.12, p.100270-100270, Article 100270

2022

Volltextzugriff (PDF)

Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018)

Transfusion medicine and hemotherapy, 2021-10, Vol.48 (5), p.272-283

2021

Volltextzugriff (PDF)

SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission

Transfusion (Philadelphia, Pa.), 2020-06, Vol.60 (6), p.1119-1122

2020

Volltextzugriff (PDF)

Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis

npj vaccines, 2022-07, Vol.7 (1), p.76-76, Article 76

2022

Volltextzugriff (PDF)

Regulatory Measures to Improve the Safety of CAR-T-Cell Treatment

Transfusion medicine and hemotherapy, 2023-06, Vol.50 (3), p.218-225

2023

Volltextzugriff (PDF)

Frequencies and causes of ABO-incompatible red cell transfusions in France, Germany and the United Kingdom

British journal of haematology, 2024-10

2024

Volltextzugriff (PDF)

A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data

Vox sanguinis, 2024-09, Vol.119 (9), p.953-962

2024

Volltextzugriff (PDF)

The role of isoagglutinins in intravenous immunoglobulin-related hemolysis

Transfusion (Philadelphia, Pa.), 2015-07, Vol.55 (S2), p.S13-S22

2015

Volltextzugriff (PDF)

Impact of hepatitis E virus testing on the safety of blood components in Germany – results of a simulation study

Vox sanguinis, 2018-11, Vol.113 (8), p.811-813

2018

Volltextzugriff (PDF)

Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013)

Transfusion medicine and hemotherapy, 2015-07, Vol.42 (4), p.240-246

2015

Volltextzugriff (PDF)

Mortality, Morbidity and Related Outcomes Following Perioperative Blood Transfusion in Patients with Major Orthopaedic Surgery: A Systematic Review

Transfusion medicine and hemotherapy, 2018-10, Vol.45 (5), p.355-367

2018

Volltextzugriff (PDF)

Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets

Transfusion (Philadelphia, Pa.), 2012-02, Vol.52 (2), p.431-439

2012

Volltextzugriff (PDF)

Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections

Transfusion medicine and hemotherapy, 2021-05, Vol.48 (3), p.154-160

2021

Volltextzugriff (PDF)

Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions

Transfusion (Philadelphia, Pa.), 2009-09, Vol.49 (9), p.1850-1858

2009

Volltextzugriff (PDF)

Safety monitoring of cell-based medicinal products (CBMPs)

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2015-11, Vol.58 (11-12), p.1239-1246

2015

Volltextzugriff (PDF)

Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany

Transfusion medicine and hemotherapy, 2014-01, Vol.41 (1), p.45-51

2014

Volltextzugriff (PDF)

Transfusion-Transmitted Bacterial Infections – Haemovigilance Data of German Blood Establishments (1997–2010)

Transfusion medicine and hemotherapy, 2011-01, Vol.38 (4), p.266-271

2011

Volltextzugriff (PDF)

Überwachung der Sicherheit von Zelltherapeutika (CBMPs)

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2015-11, Vol.58 (11-12), p.1239-1246

2015

Volltextzugriff (PDF)

Effect of first line therapy including efavirenz and two nucleoside reverse transcriptase inhibitors in HIV-infected children

European journal of medical research, 2005-12, Vol.10 (12), p.503

2005

Volltextzugriff (PDF)

Low incidence of genotypic and phenotypic resistance in paediatric HIV-infected patients on long-term first-line antiretroviral triple therapy

AIDS (London), 2001-05, Vol.15 (8), p.1077-1079

2001

Volltextzugriff (PDF)

Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children

AIDS (London), 1999-09, Vol.13 (13), p.1653-1658

1999

Volltextzugriff (PDF)

Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study

European journal of medical research, 2008-08, Vol.13 (8), p.371-378

2008

Volltextzugriff (PDF)

Nelfinavir pharmacokinetics in HIV-infected children : a comparison of twice daily and three times daily dosing

AIDS (London), 2000-07, Vol.14 (10), p.1466-1468

2000

Volltextzugriff (PDF)

Limits from the FUNK experiment on the mixing strength of hidden-photon dark matter in the visible and near-ultraviolet wavelength range

Physical review. D, 2020-08, Vol.102 (4), p.1, Article 042001

2020

Volltextzugriff (PDF)

Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process

The American journal of gastroenterology, 2010-09, Vol.105 (9), p.2060-2071

2010

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(44)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany

Blood Donation-Related Adverse Reactions: Results of an Online Survey among Donors in Germany (2018)

SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission

Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis

Regulatory Measures to Improve the Safety of CAR-T-Cell Treatment

Frequencies and causes of ABO-incompatible red cell transfusions in France, Germany and the United Kingdom

A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data

The role of isoagglutinins in intravenous immunoglobulin-related hemolysis

Impact of hepatitis E virus testing on the safety of blood components in Germany – results of a simulation study

Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013)

Mortality, Morbidity and Related Outcomes Following Perioperative Blood Transfusion in Patients with Major Orthopaedic Surgery: A Systematic Review

Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets

Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections

Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions

Safety monitoring of cell-based medicinal products (CBMPs)

Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany

Transfusion-Transmitted Bacterial Infections – Haemovigilance Data of German Blood Establishments (1997–2010)

Überwachung der Sicherheit von Zelltherapeutika (CBMPs)

Effect of first line therapy including efavirenz and two nucleoside reverse transcriptase inhibitors in HIV-infected children

Low incidence of genotypic and phenotypic resistance in paediatric HIV-infected patients on long-term first-line antiretroviral triple therapy

Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children

Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study

Nelfinavir pharmacokinetics in HIV-infected children : a comparison of twice daily and three times daily dosing

Limits from the FUNK experiment on the mixing strength of hidden-photon dark matter in the visible and near-ultraviolet wavelength range

Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process

Suchergebnisse filtern